Pelthos Therapeutics Inc.
PTHS
$25.35
$0.210.84%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -134.22% | 7.72% | 18.00% | -7.79% | -118.92% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -37.45% | -53.61% | -76.29% | 267.75% | 72.20% |
| Total Other Non-Cash Items | 52.75% | -62.16% | -61.02% | -65.47% | 292.08% |
| Change in Net Operating Assets | -1,595.92% | 845.86% | -9.39% | -98.29% | -103.65% |
| Cash from Operations | -210.44% | 65.33% | -58.33% | -490.45% | -324.45% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -37.66% | -121.74% | 31.03% | -30.08% | 25.02% |
| Total Debt Repaid | -293.02% | 99.91% | 99.91% | -- | -- |
| Issuance of Common Stock | -97.31% | -98.67% | -98.67% | 2,270.63% | 1,374.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 145.18% | 100.55% | 100.55% | -- | -- |
| Cash from Financing | 305.96% | -105.31% | -87.82% | 507.43% | 488.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 954.57% | -200.96% | -197.76% | 910.90% | 919.00% |